ExploreOutcome(Frigidity or impotence) or (lack or loss of libido) or (psychogen.dyspareunia) or (fear of ejaculation) or (premature ejaculation)
Outcome

(Frigidity or impotence) or (lack or loss of libido) or (psychogen.dyspareunia) or (fear of ejaculation) or (premature ejaculation)

Also known as: (Frigidity or impotence) or (lack or loss of libido) or (psychogen.dyspareunia) or (fear of ejaculation) or (premature ejaculation) (Frigidity or impotence) or (lack or loss of libido) or (psychogen.dyspareunia) or (fear of ejaculation) or (premature ejaculation) (disorder) Dyspareunia or fear of dyspareunia at 12 months OR
3 findings 1 paper 4 related entities View in graph →

Related entities

interventions
conditions
populations
studys

Findings (27)

None
improvement

Among 627 women who were sexually active or inactive due to fear of dyspareunia at baseline, dyspareunia decreased from 29.0% to 10.0% at 12 months after pelvic organ prolapse surgery (OR 0.3, 95% CI

Effect: improvement; OR 0.3; CI: 95% CI 0.2 – 0.4

Size: OR 0.3 CI: 95% CI 0.2 – 0.4
None
improvement

Among 627 women who were sexually active or inactive due to fear of dyspareunia at baseline, dyspareunia decreased from 29.0% to 10.0% at 12 months after pelvic organ prolapse surgery (OR 0.3, 95% CI

Effect: improvement; OR 0.3; CI: 95% CI 0.2 – 0.4

Size: OR 0.3 CI: 95% CI 0.2 – 0.4
None
improvement

Among 627 women who were sexually active or inactive due to fear of dyspareunia at baseline, dyspareunia decreased from 29.0% to 10.0% at 12 months after pelvic organ prolapse surgery (OR 0.3, 95% CI

Effect: improvement; OR 0.3; CI: 95% CI 0.2 – 0.4

Size: OR 0.3 CI: 95% CI 0.2 – 0.4
None
improvement

Among 627 women who were sexually active or inactive due to fear of dyspareunia at baseline, dyspareunia decreased from 29.0% to 10.0% at 12 months after pelvic organ prolapse surgery (OR 0.3, 95% CI

Effect: improvement; OR 0.3; CI: 95% CI 0.2 – 0.4

Size: OR 0.3 CI: 95% CI 0.2 – 0.4
None
improvement

Among 627 women who were sexually active or inactive due to fear of dyspareunia at baseline, dyspareunia decreased from 29.0% to 10.0% at 12 months after pelvic organ prolapse surgery (OR 0.3, 95% CI

Effect: improvement; OR 0.3; CI: 95% CI 0.2 – 0.4

Size: OR 0.3 CI: 95% CI 0.2 – 0.4
None
improvement

Among 627 women who were sexually active or inactive due to fear of dyspareunia at baseline, dyspareunia decreased from 29.0% to 10.0% at 12 months after pelvic organ prolapse surgery (OR 0.3, 95% CI

Effect: improvement; OR 0.3; CI: 95% CI 0.2 – 0.4

Size: OR 0.3 CI: 95% CI 0.2 – 0.4
None
improvement

Among 627 women who were sexually active or inactive due to fear of dyspareunia at baseline, dyspareunia decreased from 29.0% to 10.0% at 12 months after pelvic organ prolapse surgery (OR 0.3, 95% CI

Effect: improvement; OR 0.3; CI: 95% CI 0.2 – 0.4

Size: OR 0.3 CI: 95% CI 0.2 – 0.4
None
improvement

Among 627 women who were sexually active or inactive due to fear of dyspareunia at baseline, dyspareunia decreased from 29.0% to 10.0% at 12 months after pelvic organ prolapse surgery (OR 0.3, 95% CI

Effect: improvement; OR 0.3; CI: 95% CI 0.2 – 0.4

Size: OR 0.3 CI: 95% CI 0.2 – 0.4
None
improvement

Among 627 women who were sexually active or inactive due to fear of dyspareunia at baseline, dyspareunia decreased from 29.0% to 10.0% at 12 months after pelvic organ prolapse surgery (OR 0.3, 95% CI

Effect: improvement; OR 0.3; CI: 95% CI 0.2 – 0.4

Size: OR 0.3 CI: 95% CI 0.2 – 0.4
None
improvement

Among 627 women who were sexually active or inactive due to fear of dyspareunia at baseline, dyspareunia decreased from 29.0% to 10.0% at 12 months after pelvic organ prolapse surgery (OR 0.3, 95% CI

Effect: improvement; OR 0.3; CI: 95% CI 0.2 – 0.4

Size: OR 0.3 CI: 95% CI 0.2 – 0.4
None
improvement

Among 627 women who were sexually active or inactive due to fear of dyspareunia at baseline, dyspareunia decreased from 29.0% to 10.0% at 12 months after pelvic organ prolapse surgery (OR 0.3, 95% CI

Effect: improvement; OR 0.3; CI: 95% CI 0.2 – 0.4

Size: OR 0.3 CI: 95% CI 0.2 – 0.4
None
improvement

Among 627 women who were sexually active or inactive due to fear of dyspareunia at baseline, dyspareunia decreased from 29.0% to 10.0% at 12 months after pelvic organ prolapse surgery (OR 0.3, 95% CI

Effect: improvement; OR 0.3; CI: 95% CI 0.2 – 0.4

Size: OR 0.3 CI: 95% CI 0.2 – 0.4
None
improvement

Among 627 women who were sexually active or inactive due to fear of dyspareunia at baseline, dyspareunia decreased from 29.0% to 10.0% at 12 months after pelvic organ prolapse surgery (OR 0.3, 95% CI

Effect: improvement; OR 0.3; CI: 95% CI 0.2 – 0.4

Size: OR 0.3 CI: 95% CI 0.2 – 0.4
None
improvement

Among 627 women who were sexually active or inactive due to fear of dyspareunia at baseline, dyspareunia decreased from 29.0% to 10.0% at 12 months after pelvic organ prolapse surgery (OR 0.3, 95% CI

Effect: improvement; OR 0.3; CI: 95% CI 0.2 – 0.4

Size: OR 0.3 CI: 95% CI 0.2 – 0.4
None
improvement

Among 627 women who were sexually active or inactive due to fear of dyspareunia at baseline, dyspareunia decreased from 29.0% to 10.0% at 12 months after pelvic organ prolapse surgery (OR 0.3, 95% CI

Effect: improvement; OR 0.3; CI: 95% CI 0.2 – 0.4

Size: OR 0.3 CI: 95% CI 0.2 – 0.4
None
improvement

Among 627 women who were sexually active or inactive due to fear of dyspareunia at baseline, dyspareunia decreased from 29.0% to 10.0% at 12 months after pelvic organ prolapse surgery (OR 0.3, 95% CI

Effect: improvement; OR 0.3; CI: 95% CI 0.2 – 0.4

Size: OR 0.3 CI: 95% CI 0.2 – 0.4
None
improvement

Among 627 women who were sexually active or inactive due to fear of dyspareunia at baseline, dyspareunia decreased from 29.0% to 10.0% at 12 months after pelvic organ prolapse surgery (OR 0.3, 95% CI

Effect: improvement; OR 0.3; CI: 95% CI 0.2 – 0.4

Size: OR 0.3 CI: 95% CI 0.2 – 0.4
None
improvement

Among 627 women who were sexually active or inactive due to fear of dyspareunia at baseline, dyspareunia decreased from 29.0% to 10.0% at 12 months after pelvic organ prolapse surgery (OR 0.3, 95% CI

Effect: improvement; OR 0.3; CI: 95% CI 0.2 – 0.4

Size: OR 0.3 CI: 95% CI 0.2 – 0.4
None
improvement

Among 627 women who were sexually active or inactive due to fear of dyspareunia at baseline, dyspareunia decreased from 29.0% to 10.0% at 12 months after pelvic organ prolapse surgery (OR 0.3, 95% CI

Effect: improvement; OR 0.3; CI: 95% CI 0.2 – 0.4

Size: OR 0.3 CI: 95% CI 0.2 – 0.4
None
improvement

Among 627 women who were sexually active or inactive due to fear of dyspareunia at baseline, dyspareunia decreased from 29.0% to 10.0% at 12 months after pelvic organ prolapse surgery (OR 0.3, 95% CI

Effect: improvement; OR 0.3; CI: 95% CI 0.2 – 0.4

Size: OR 0.3 CI: 95% CI 0.2 – 0.4
None
improvement

Among 627 women who were sexually active or inactive due to fear of dyspareunia at baseline, dyspareunia decreased from 29.0% to 10.0% at 12 months after pelvic organ prolapse surgery (OR 0.3, 95% CI

Effect: improvement; OR 0.3; CI: 95% CI 0.2 – 0.4

Size: OR 0.3 CI: 95% CI 0.2 – 0.4
None
improvement

Among 627 women who were sexually active or inactive due to fear of dyspareunia at baseline, dyspareunia decreased from 29.0% to 10.0% at 12 months after pelvic organ prolapse surgery (OR 0.3, 95% CI

Effect: improvement; OR 0.3; CI: 95% CI 0.2 – 0.4

Size: OR 0.3 CI: 95% CI 0.2 – 0.4
None
improvement

Among 627 women who were sexually active or inactive due to fear of dyspareunia at baseline, dyspareunia decreased from 29.0% to 10.0% at 12 months after pelvic organ prolapse surgery (OR 0.3, 95% CI

Effect: improvement; OR 0.3; CI: 95% CI 0.2 – 0.4

Size: OR 0.3 CI: 95% CI 0.2 – 0.4
None
improvement

Among 627 women who were sexually active or inactive due to fear of dyspareunia at baseline, dyspareunia decreased from 29.0% to 10.0% at 12 months after pelvic organ prolapse surgery (OR 0.3, 95% CI

Effect: improvement; OR 0.3; CI: 95% CI 0.2 – 0.4

Size: OR 0.3 CI: 95% CI 0.2 – 0.4
None
improvement

Among 627 women who were sexually active or inactive due to fear of dyspareunia at baseline, dyspareunia decreased from 29.0% to 10.0% at 12 months after pelvic organ prolapse surgery (OR 0.3, 95% CI

Effect: improvement; OR 0.3; CI: 95% CI 0.2 – 0.4

Size: OR 0.3 CI: 95% CI 0.2 – 0.4
None
improvement

Among 627 women who were sexually active or inactive due to fear of dyspareunia at baseline, dyspareunia decreased from 29.0% to 10.0% at 12 months after pelvic organ prolapse surgery (OR 0.3, 95% CI

Effect: improvement; OR 0.3; CI: 95% CI 0.2 – 0.4

Size: OR 0.3 CI: 95% CI 0.2 – 0.4
None
improvement

Among 627 women who were sexually active or inactive due to fear of dyspareunia at baseline, dyspareunia decreased from 29.0% to 10.0% at 12 months after pelvic organ prolapse surgery (OR 0.3, 95% CI

Effect: improvement; OR 0.3; CI: 95% CI 0.2 – 0.4

Size: OR 0.3 CI: 95% CI 0.2 – 0.4

Papers (1)